|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 |
28 Feb 2025 12:15 AM
|
|||||
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 |
28 Feb 2025 12:15 AM
|
|||||
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 3.6 | 5 | Advertising and PR | United States |
21 Feb 2025 02:19 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 320 GRE | 4 | Finance: Venture Capital | India |
21 Feb 2025 04:26 AM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 645 GMAT Focus 690 GMAT Classic 331 GRE |
9 | 4 | Finance | India |
20 Feb 2025 10:00 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 3.1 | 4 | Technology | United States |
20 Feb 2025 09:55 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 327 GRE | 7 | Technology | United States |
19 Feb 2025 10:32 PM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 645 GMAT Focus 685 GMAT Focus |
3.6 | 4 | Consulting | United States |
19 Feb 2025 03:57 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 3.9 | 5 | Finance: Venture Capital | United States |
19 Feb 2025 12:24 PM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 320 GRE | 6 | Healthcare/Pharmaceuticals | United Kingdom |
19 Feb 2025 08:57 AM
|
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 655 GMAT Focus | 3.7 | 8 | Pharmaceuticals and Biotech | Korea, Republic of |
19 Feb 2025 08:49 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 735 GMAT Focus | 3.6 | 7 | Consulting | United States |
19 Feb 2025 08:34 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 655 GMAT Focus 705 GMAT Focus |
3.4 | 4 | Finance: Private Equity | United States |
19 Feb 2025 08:29 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 615 GMAT Focus 675 GMAT Focus |
3.2 | 7 | Consulting | United States |
19 Feb 2025 08:18 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 6.1 | 5 | Consumer Packaged Goods | India |
19 Feb 2025 08:18 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 3.7 | 6 | Real Estate | Romania |
19 Feb 2025 08:17 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 695 GMAT Focus | 3.2 | 0 | Healthcare/Pharmaceuticals | India |
19 Feb 2025 08:16 AM
|
| Full Time MBA |
Denied without Interview
|
Round 2 | 2025 | 735 GMAT Focus | 3.5 | 1 | Other | United States |
19 Feb 2025 08:15 AM
|
| Full Time MBA |
Admitted
|
2027 | 0 | Other | India |
03 Jan 2025 10:30 AM
|
|||
| Full Time MBA |
Denied with Interview
|
Round 2 | 2024 | 327 GRE | 3.6 | 8 | Other | India |
19 Dec 2024 10:40 PM
|